TIGIT is expressed on activated T cells, regulatory T cells, and NK cells and binds two ligands CD155 (PVR) and CD112 (PVRL2 or Necl5), that are expressed on antigen-presenting cells (APCs)10,11 and tumor cells12,13. The gene discussed is TIGIT; the disease is neoplasm.